Analysis of survival data from a randomized trial with all-or-none compliance: Estimating the cost-effectiveness of a cancer screening program

Journal of the American Statistical Association

Volumn 93, Issue 443, 1998, Pages 929-934

  Baker, Stuart G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

All or none compliance; Cancer screening; Composite linear models; Cost effectiveness; Kaplan Meier; Missing data; Noncompliance; Survival analysis

Indexed keywords

EID: 0032331360     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1998.10473749     Document Type: Article

References (44)

1. Angrist, J. D., Imbens, G. W., and Rubin, D. R. (1996), "Identification of Causal Effects Using Instrumental Variables," Journal of the American Statistical Association, 91, 444-455.
2. Baker, S. G. (1992), "A Simple Method for Computing the Observed Information Matrix When Using the EM Algorithm With Categorical Data," Journal of Computational and Graphical Statistics, 1, 63-76.
3. Baker, S. G. (1994a), "Composite Linear Models for Incomplete Multinomial Data," Statistics in Medicine, 13, 609-622.
4. Baker, S. G. (1994b), "Regression Analysis of Grouped Survival Data With Incomplete Covariates: Nonignorable Missing-Data and Censoring Mechanisms," Biometrics, 50, 821-826.
5. Baker, S. G. (1997), "AIl-or-None Compliance," The Encyclopedia of Statistical Sciences, eds. S. Kotz, C. Read, and D. Banks. New York: Wiley, pp. 134-138.
6. Baker, S. G. (in press), 'The Paired Availability Design: An Update," in Mon-randomized Comparative Clinical Studies, eds. U. Abel and A. Koch, Düsseldorf: Symposiom Publishing.
7. Baker, S. G., and Lindeman, K. S. (1994), "The Paired Availability Design: A Proposal for Evaluating Epidural Analgesia During Labor," Statistics in Medicine, 13, 2269-2278.
8. Bloom, H. S. (1984), "Accounting for No-Shows in Experimental Evaluation Designs," Evaluation Review, 8, 225-246.
9. Connor, R. J., and Prorok, P. C. (1994), "Issues in the Mortality Analysis of Randomized Controlled Trials of Cancer Screening," Controlled Clinical Trials, 15, 81-99.
10. Connor, R. J., Prorok, P. C., and Weed, D. L. (1991), 'The Case-Control Design and the Assessment of the Efficacy of Cancer Screening," Journal of Clinical Epidemiology, 44, 1215-1221.
11. Cuzick, J., Edward, R., and Segnan, N. (1997), "Adjusting for Non-Compliance and Contamination in Randomized Clinical Trials," Statistics in Medicine, 16, 1017-1029.
12. Efron, B., and Feldman, D. (1991), "Compliance as an Explanatory Variable in Clinical Trials," Journal of the American Statistical Association, 86, 9-26.
13. Frangakis, C. E., and Rubin, D. R. (1998), "Addressing the Invalidity of Intention-to-Treat Analysis in the Presence of Both Treatment-Noncompliance and Outcome-Nonresponse," technical report, Harvard University.
14. Glasziou, P. P. (1992), "Meta-Analysis Adjusting for Compliance: The Example of Screening for Breast Cancer," Journal of Clinical Epidemiology, 45, 1251-1256.
15. Goetghebeur, E., and Molenberghs, G. (1995), "Estimating Causal Parameters in Placebo-Controlled Clinical Trials With Binary Outcome and Ordered Compliance," in Proceedings of the Biometric Section, American Statistical Association, pp. 25-33.
16. Goetghebeur, E., and Molenberghs, G. (1996), "Causal Inference in a Placebo-Controlled Clinical Trial With Binary Outcome and Ordered Compliance," Journal of the American Statistical Association, 91, 928-934.
17. Ihm, P. (1981), "Ein lineares modell fur die randomisierungsplane von Zelen." In Medizinishe Informatik und Statistik, Vol. 33, Therapiestudien, eds. N. Victor, J. Dudeck, and E. P. Broszio: Berlin: Springer, pp. 176-184 (in German).
18. Imbens, G., and Angrist, J. (1994), "Identification and Estimation of Local Average Treatment Effects," Econometrica, 62, 467-476.
19. Imbens, G. W., and Rubin, D. B. (1997), "Bayesian Inference for Causal Effects in Randomized Experiments With Noncompliance," The Annals of Statistics, 25, 305-327.
20. Little, R. J. A., and Rubin, D. B. (1987), Statistical Analysis With Missing Data, New York: Wiley.
21. Manning, W. G., Fryback, D. G., and Weinstein, M. C., (1996), "Reflecting Uncertainty in Cost-Effcctiveness Analysis," in Cost-Effectiveness in Health and Medicine, eds. M. E. Gold, J. E. Siegel, L. B. Russell, and M. C. Weinstein, New York: Oxford University Press, pp. 247-275.
22. Manski, C. F. (1990), "Nonparametric Bounds on Treatment Effects," American Economic Reviews, Papers and Proceedings, 80, 319-323.
23. Mark, S. D., and Robins, J. M. (1993a), "A Method for the Analysis of Randomized Trials With Compliance Information: An Application to the Multiple Risk Factor Intervention Trial," Controlled Clinical Trials, 14, 79-97.
24. Mark, S. D., and Robins, J. M. (1993b), "Estimating the Causal Effect of Smoking Cessation in the Presence of Confounding Factors Using a Rank Preserving Structural Failure Time Model," Statistics in Medicine, 12, 1605-1625.
25. Mushlin, A. I., and Fintor, M. A. (1992), "Is Screening for Breast Cancer Cost-Effective?' Cancer, 69, 1957-1962.
26. Newcombe, R. G. (1988), "Explanatory and Pragmatic Estimates of the Treatment Effect When Deviations From Allocated Treatment Occur," Statistics in Medicine, 7, 1179-1186.
27. Pearl, J. (1995), ''Causal Inference From Indirect Experiments," Artificial Intelligence in Medicine Journal, 7, 561-582.
28. Permutt, T., and Hebei, J. R. (1989), "Simultaneous-Equation Estimation in a Clinical Trial of the Effect of Smoking on Birth Weight," Biometrics, 45, 619-622.
29. Powers, D. E., and Swinton, S. S. (1984), "Effects of Self-Study for Coach-able Test Item Types," Journal of Educational Psychology, 76,266-278.
30. Ries, L. A. G., Hankey, B. F., and Edwards, B. K. (1984), Cancer Statistics Review 1973-87, NIH Publication No. 90-2789, Washington, DC: U.S. Department of Health and Human Services.
31. Robins, J. M. (1989), 'The Analysis of Randomized and Non-Randomized AIDS Treatment Trials Using a New Approach to Causal Inference in Longitudinal Studies," in Health Service Research Methodology: A Focus on AIDS, eds. L. Sechrest, H. Freeman, and A. Bailey, Washington, DC: U.S. Public Health Service.
32. Robins, J. M. (1992), "Estimation of the Time-Dependent Accelerated Failure Time Model in the Presence of Confounding Factors," Biometrika, 79, 321-334.
33. Robins, J. M., and Greenland, S. (1994), "Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized Trial," Journal of the American Statistical Association, 89, 737-749.
34. Robins, J. M., and Tsiatis, A. (1991), "Correcting for Non-Compliance in Randomized Trials Using Rank Preserving Structural Failure Time Model," Communications in Statistics, Part A-Theory and Methods, 20, 2609-2631.
35. Rochon, J. (1995), "Supplementing the Intent-to-Treat Analysis: Accounting for Covariates Observed Postrandomization in Clinical Trials," Journal of the American Statistical Association, 90, 292-300.
36. Schwartz, D., and Lellouch, Z. (1967), "Explanatory and Pragmatic Attitudes in Therapeutic Trials," Journal of Chronic Disease, 20, 637-648.
37. Shapiro, S., Vcnet, W., Strax, P., and Vcnct, L. (1988), Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986, Baltimore: The Johns Hopkins University Press.
38. Sommer, A., and Zeger, S. L. (1991), ''On Estimating Efficacy from Clinical Trials," Statistics in Medicine, 10, 45-52; "Correction," 13, 1897 (1994).
39. Spencer, G. (1988), Projections of the Population of the United States, by Age, Sex, and Race: 1988 to 2080, Series P-25 No. 1018, Washington, DC: U.S. Department of Commerce.
40. Strax, P., Venet, L., Shapiro, S., Gross, S., and Venci, W. (1970), "Breast Cancer Found on Repetitive Examination in Mass Screening," Archives of Environmental Health, 20, 761.
41. Weinstein, M. C., Fineberg, H. V., Elstein, A. S., Frazier, H. S., Neuhauser, D., Neutra, R. R., and McNeil, B. J. (1980), Clinical Decision Analysis, Philadelphia: W. B. Saunders.
42. Wolfram, S. (1991), Mathematica: A System for Doing Mathematics by Computer, Redwood City, CA: Addison-Wesley.
43. Zelen, M. (1979), "A New Design for Randomized Clinical Trials," New England Journal of Medicine, 300, 1242-1245.
44. Zelen, M. (1990), "Randomized Consent Designs for Clinical Trials: An Update," Statistics in Medicine, 9, 645-656.